Alternatives to Deep Science Ventures

A deep tech ecosystem providing lab space, expert training, and venture capital for startups.

Developing and industrializing cellulose-based superabsorbent materials as a fossil-free and biodegradable alternative.

Enzyme-based technology to break down alcohol in the stomach.

Developing high-performance, compostable foams from bacterial cellulose to replace fossil-based plastics.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

Developing circular biomass technology.

Cultivating wood directly into its final shape, 10,000x faster than forestry.

Enabling sustainable and scalable manufacturing of complex, high-value biomolecules through enzymatic biomanufacturing.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global early-stage venture capital firm that builds and invests in the next generation of founders and technology.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing next-generation nanozyme catalysts to enable a more sustainable and efficient chemical production industry.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Developing novel therapeutics to restore gut lymphatic function.

A venture capital firm focused on deeptech investments.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.